(PRWEB) April 25, 2014
Michael Tansey, BSC MB ChB MD FFPM, former Chief Medical Officer of Pharmacia Corporation, has joined PhESi as a strategic partner.
Dr. Tansey is an established visionary leader in the pharmaceutical industry, with extensive international line management, strategic oversight, project development and process redesign experience in large global pharmaceutical (Hoechst, Glaxo, Rhone-Poulenc-Rorer and Pharmacia Corporation) as well as in small to medium-sized biotechnology companies.
PhESi has built an extensive clinical development database, including the largest clinical trial site/investigator database, with over 500,000 independent investigators worldwide. Using patent protected method, PhESi Clinical Trial Site Selection Services consistently provide superior enrollment results to its clients.
PhESi also provides clinical trial feasibility analysis, benchmarking, and process improvement support.
Joining forces between Dr. Tansey and PhESi will further enhance and expand our ability to serve our clients.
For more information, go to http://www.phesi.com